gip/glp-1 receptor agonist drugs The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology The Effects of Dual GLP-1/GIP

Eghdami S, Eissazade N, Heidari Mokarar M, Boroon M, Orsolini L, Shalbafan M

Dual-fluorescence imaging further confirmed its strong in vitro transdermal delivery capacity, providing a solid foundation for subsequent biological evaluations

GLP-1 Receptor Agonists for Individualized Treatment of Type 2 Diabetes Mellitus

Peptides derived from growth factors: Exploring their diverse impact from antimicrobial properties to neuroprotection

The acetyl group attached to the carnitine molecule enhances its ability to pass across the blood-brain barrier and enter the brain, where it acts as a powerful antioxidant

Any additional information required to reanalyze the data reported in this paper is available from the corresponding author upon request